TECLens
New York
About TECLens
TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, and more.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $19.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2025)
- Website: teclens.com
Industries & Categories
Health Care, Medical Device
Canonical: https://fsome.com/organization/teclens-83998 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.